Summary of Research Activities

Basic and Clinical Research Program | Summary of Research Activities

Causation and Etiological Studies
Darell Bigner, M.D., Ph.D.
Faith Davis, Ph.D., University of Illinois, Chicago
Henry Friedmam, M.D.
Dora Il’yasova, Ph.D.
Nicholas Vick, M.D., Evanston Hospital, Northwestern University, Chicago

Identification of Molecular Alterations in Medulloblastoma
Cory Adamson, M.D., Ph.D.
Darell Bigner, M.D., Ph.D.
Roger McLendon, M.D.
Duane Mitchell, M.D., Ph.D.
John Sampson, M.D., Ph.D.
Hai Yan, M.D., Ph.D.

Sonic Hedgehog Signaling in Neural Development and Tumorigenesis
Robert Wechsler-Reya, Ph.D.

Identification of Medulloblastoma Cell Membrane Proteins that Could Serve as Targets for Drug Development
Darell Bigner, M.D., Ph.D.
Chien-Tsun Kuan, Ph.D.
Madan Kwatra, Ph.D.

Array Comparative Genomic Hybridization of Malignant Gliomas
Simon G. Gregory, Ph.D.
Roger McLendon, M.D.
Darell D. Bigner, M.D., Ph.D

Genomics of Malignant Gliomas
Cory Adamson, M.D., Ph.D.
Darell Bigner, M.D., Ph.D.
Bryan Cullen, Ph.D.
Allan Friedman, M.D.
Simon Gregory, Ph.D.
Roger McLendon, M.D.
Joseph Nevins, Ph.D.
Ahmed Rasheed, Ph.D.
John Sampson, M.D., Ph.D.
Hai Yan, M.D., Ph.D.

Mechanisms of Glioma Invasion and Signal Transduction Inhibitors
Wei Chen, Ph.D. (?)
Henry Friedman, M.D.
Matthias Gromeier, M.D.
Xiao-Fan Wang, Ph.D.

Mechanisms of Drug Resistance and Their Reversal
Henry Friedman, M.D.

Development of Armed and Unarmed Monoclonal Antibodies for the Treatment of Malignant Gliomas and Medulloblastomas
Darell Bigner, M.D., Ph.D.
Chien-Tsun Kuan, Ph.D.
Michael Zalutsky, Ph.D.

New Radiolabeling Technology and Isotopes (211At and 177Lu) for Peptides and Monoclonal Antibodies
Ganesan Vaidyanathan, Ph.D.
Michael Zalutsky, Ph.D.

Basic, Translational, and Clinical Research for Radionuclide Therapy of Human Glioma
Darell Bigner, M.D., Ph.D.
Michael Zalutsky, Ph.D.

Clinical Dendritic Cell and Cell-Mediated Immunotherapy of Gliomas
Gary Archer, Ph.D.
Darell Bigner, M.D., Ph.D.
Gerald Grant, M.D.
Sridharan Gururangan, M.B., Ch.B.
Duane Mitchell, M.D., Ph.D.
John Sampson, M.D., Ph.D.

Anti-Angiogenic Agents for Malignant Brain Tumor Therapy
Henry Friedman, M.D.

Viral Oncolytic Therapy
Matthias Gromeier, M.D.
John Sampson, M.D., Ph.D.

Molecular Imaging
R. Edward Coleman, M.D.
Ronald Jaszczak, Ph.D.
Michael Zalutsky, Ph.D.

Neural Stem Cells
Chay Kuo, M.D., Ph.D.
James McNamara, M.D., Ph.D.

Neurobiology and Functional Imaging
James Provenzale, M.D.
Allen Song, Ph.D.

Apoptosome Activation in Brain Cancer
Sally Kornbluth, Ph.D.

Tumor Stem Cell Therapy
Darell Bigner, M.D., Ph.D.
Hui-Wen Lo, Ph.D.

Clinical Investigation
Darell Bigner, M.D., Ph.D.
Annick Desjardins, M.D.
Allan Friedman, M.D.
Henry Friedman, M.D.
Gerald Grant, M.D.
Sridharan Gururangan, M.B., CH.B.
Roger McLendon, M.D.
Katherine Peters, M.D., Ph.D.
John Sampson, M.D., Ph.D.

Quality of Life and Survivorship
Melanie Bonner, Ph.D.
Lee Jones, Ph.D.
Katherine Peters, M.D., Ph.D.
Renee Raynor, Ph.D.


 





This article comes from The Preston Robert Tisch Brain Tumor Center at Duke   http://www.cancer.duke.edu/btc
The URL for this story is:   http://www.cancer.duke.edu/btc/modules/Research3/index.php?id=15